We are live on ! Find out more
DVC

Deer VII & Co Portfolio holdings

AUM $317M
1-Year Est. Return 30.89%
This Fund
S&P 500
This Quarter Est. Return
+3.01%
1 Year Est. Return
+30.89%
3 Year Est. Return
+241.3%
5 Year Est. Return
+1,036.06%
10 Year Est. Return
AUM
$244M
AUM Growth
-$91.7M
Cap. Flow
-$95.1M
Cap. Flow %
-39%
Top 10 Hldgs %
100%
Holding
7
New
Increased
Reduced
2
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
TPST icon
Tempest Therapeutics
TPST
+$94.7M
2
TWTR
Twitter, Inc.
TWTR
+$378K

Sector Composition

Rank Sector Weight
1 Technology 89.62%
2 Healthcare 10.35%
3 Communication Services 0.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WIX icon
1
WIX.com
WIX
$2.45B
$152M 62.39%
7,935,978
TWOU
2
DELISTED
2U Inc
TWOU
$66.4M 27.23%
86,487
VSTM icon
3
Verastem
VSTM
$547M
$12.1M 4.97%
99,197
TPST icon
4
Tempest Therapeutics
TPST
$13.9M
$8.31M 3.41%
82
-711
-90% -$94.7M
TARA icon
5
Protara Therapeutics
TARA
$221M
$3.3M 1.35%
7,878
DARE icon
6
Dare Bioscience
DARE
$17.8M
$1.5M 0.62%
1,389
TWTR
7
DELISTED
Twitter, Inc.
TWTR
$82K 0.03%
1,809
-8,517
-82% -$378K

Similar funds

Deer VII & Co's Q1 2015 Portfolio in Review

As of Q1 2015, Deer VII & Co held 7 positions worth $244M, down 27% from $335M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Deer VII & Co withdrew a net $95.1M in Q1 2015, reducing 2 holdings. Its largest reduction was Tempest Therapeutics, cutting an estimated $94.7M.

By sector, the portfolio is most concentrated in Technology at 90% of assets, up from 65% a quarter earlier, followed by Healthcare and Communication Services.

  • Deer VII & Co's biggest Q1 2015 reduction was Tempest Therapeutics, cutting an estimated $94.7M.
  • Deer VII & Co's ten largest holdings make up 100% of its $244M portfolio in Q1 2015.
  • Deer VII & Co opened 0 new positions and closed 0 in Q1 2015.
  • Deer VII & Co's portfolio value fell 27% quarter-over-quarter to $244M.

Based on Deer VII & Co's 13F filing for Q1 2015, filed 14 May 2015.